Related Experiment Video
Updated: Jul 16, 2026
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Second-order interactions with the treatment groups in controlled clinical trials
Shyang-Yun Pamela K Shiao1, Chul W Ahn, Kouhei Akazawa
1University of Houston-Victoria, University of Houston System at Sugar Land, United States. ShiaoP@uhv.edu
Computer Methods and Programs in Biomedicine
|February 17, 2007
Summary
Randomized controlled trials (RCTs) often have overlooked second-order interactions. Minimization methods in RCTs reveal these interactions, improving treatment effect analysis and study power.
Area of Science:
- Biostatistics
- Clinical Trials Methodology
- Statistical Modeling
Background:
- Second-order interactions involving group characteristics are inherent in randomized controlled trials (RCTs).
- Simple randomization or stratification methods may obscure these interactions, while minimization methods can reveal them more clearly.
- Understanding and accounting for these interactions is crucial for accurate treatment effect evaluation.
Purpose of the Study:
- To examine the occurrence and impact of significant second-order interactions in real-world randomized controlled trial data.
- To demonstrate how minimization methods in RCTs can better balance group characteristics and reveal interactions compared to simpler methods.
- To highlight the importance of evaluating interaction effects for maximizing treatment effect power in RCTs.
Main Methods:
- Utilized real data from a randomized controlled trial.
- Employed minimization methods to balance distributions of four key stratified factors.
- Conducted analyses for three-way second-order interactions, including six additional confounding variables (total 10 variables).
- Applied stepwise regression with piecewise linear functions for variable selection.
Main Results:
- The minimization method successfully balanced distributions of the selected factors in the RCT.
- Identified 8 significant second-order interactions between treatment groups and other variables.
- Confirmed that interaction effects significantly influence treatment outcomes in RCTs.
Conclusions:
- Significant second-order interactions are prevalent in RCTs and can be effectively identified using minimization methods.
- Evaluating interaction effects is essential for maximizing the power and accuracy of treatment effect assessments in RCTs.
- Stepwise regression with piecewise linear functions offers a valuable approach for detecting significant interaction variables impacting RCT outcomes.
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:11Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
01:15Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
01:16Crossover Experiments
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.